---
document_datetime: 2025-05-07 12:03:40
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/cabazitaxel-accord-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: cabazitaxel-accord-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 4.6043285
conversion_datetime: 2025-12-31 01:18:00.254468
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Cabazitaxel Accord

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproductlifecycleprocedures,please alsorefertoEPAR-Proceduralstepstakenandscientific informationafterauthorisation(archive).

| Applicationnumber    | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|----------------------|----------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Variation typeIA_IN/ | This was an application for a group of | 07/05/2025                          |                                          | Annex II and                    |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | variations. B.II.b.2.cReplacement or addition of a manufacturerresponsibleforimportation and/orbatch release-B.11.b.2.c.2Including batch control/testing-Accepted B.II.b.1Replacementor addition of a manufacturingsiteforpart or all of the manufacturingprocessof thefinished product - B.1I1.b.1.a Secondary packaging site - Accepted                                                                                                                                 |            |     | PL   | EMA/VR/0000269507   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|---------------------|
| Variation type IA / | B.II.d.2 Change in test procedurefor the finished product - B.II.d.2.a Minor changes to an approved test procedure - Accepted                                                                                                                                                                                                                                                                                                                                             | 10/04/2025 | N/A |      | EMA/VR/0000265287   |
| Variation typeIA/   | Thiswasanapplicationforagroupof variations. A.5Change in thename and/or address of a manufacturer/importer of the finished product(includingbatchreleaseor quality control testing sites)-A.5.bThe activities forwhichthemanufacturer/importeris responsible do not include batch release - Accepted A.5Changein thename and/or address of a manufacturer/importer of the finished product (including batch release or quality control testing sites)-A.5.bThe activities | 09/01/2025 | N/A |      | EMA/VR/0000244079   |

<div style=\"page-break-after: always\"></div>

| for which the manufacturer/importer is responsible do not include batch release - Accepted A.ADMINISTRATIVECHANGES-A.7 Deletion ofmanufacturingsitesfor an active substance, intermediate or finished product, packaging site, manufacturer responsible for batch release, site where batch control takes place,orsupplier of a startingmaterial, reagent or excipient (when mentioned in the dossier)*-Accepted   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|